ReWalk Robotics Ltd. (NASDAQ:LFWD) Short Interest Up 214.2% in March

ReWalk Robotics Ltd. (NASDAQ:LFWD) saw a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 2,510,000 shares, an increase of 214.2% from the February 28th total of 798,900 shares. Based on an average daily trading volume, of 2,450,000 shares, the days-to-cover ratio is presently 1.0 days. Approximately 26.8% of the company’s stock are sold short.

Insider Activity

In other news, major shareholder Global Fund Lp Lind II sold 381,676 shares of the stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $3.36, for a total value of $1,282,431.36. Following the transaction, the insider now directly owns 1,049,430 shares of the company’s stock, valued at $3,526,084.80. This represents a 26.67 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 2.50% of the stock is currently owned by insiders.

ReWalk Robotics Stock Performance

Shares of LFWD stock traded down $0.09 during trading hours on Friday, hitting $1.79. 286,689 shares of the company were exchanged, compared to its average volume of 669,199. The firm has a market cap of $19.03 million, a P/E ratio of -0.72 and a beta of 1.73. The company has a 50 day simple moving average of $1.67 and a two-hundred day simple moving average of $2.10. ReWalk Robotics has a fifty-two week low of $1.25 and a fifty-two week high of $6.00.

ReWalk Robotics (NASDAQ:LFWD) last issued its quarterly earnings data on Friday, March 7th. The company reported ($1.73) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.20) by ($1.53). ReWalk Robotics had a negative net margin of 77.21% and a negative return on equity of 43.02%. The business had revenue of $7.55 million for the quarter, compared to analyst estimates of $7.30 million. As a group, sell-side analysts expect that ReWalk Robotics will post -1.78 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. Lake Street Capital reduced their target price on shares of ReWalk Robotics from $4.50 to $4.00 and set a “buy” rating for the company in a research report on Tuesday, March 11th. HC Wainwright reiterated a “buy” rating and issued a $13.00 price target on shares of ReWalk Robotics in a research note on Tuesday, March 11th. Finally, Laidlaw started coverage on shares of ReWalk Robotics in a report on Monday, February 10th. They set a “buy” rating and a $10.00 price target on the stock.

About ReWalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.